US Stock MarketDetailed Quotes

ADVM Adverum Biotechnologies

Watchlist
  • 5.3700
  • -0.3500-6.12%
Close Dec 13 16:00 ET
  • 5.3700
  • 0.00000.00%
Post 16:00 ET
111.71MMarket Cap-0.90P/E (TTM)

Adverum Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.66%-21.12M
14.65%-19.84M
-3.72%-23.25M
15.90%-90.9M
-15.44%-21.33M
24.82%-23.91M
19.50%-23.25M
22.53%-22.41M
-0.24%-108.09M
28.43%-18.48M
Net income from continuing operations
17.49%-27.13M
41.36%-18.48M
14.69%-24.79M
24.18%-117.17M
27.56%-23.71M
18.06%-32.89M
28.00%-31.51M
23.35%-29.06M
-6.18%-154.54M
4.86%-32.74M
Operating gains losses
----
----
----
-59.02%50K
-266.67%-35K
----
----
----
--122K
--21K
Depreciation and amortization
-41.02%890K
-37.68%956K
-37.37%997K
-13.54%5.64M
-41.06%1.01M
-15.60%1.51M
-4.30%1.53M
11.72%1.59M
40.54%6.53M
29.50%1.71M
Other non cash items
-90.00%558K
-89.72%533K
-66.32%487K
396.68%13.03M
-22.52%819K
1,042.40%5.58M
361.21%5.18M
39.85%1.45M
10,592.00%2.62M
887.85%1.06M
Change In working capital
187.00%2.11M
-187.65%-6.36M
-125,933.33%-3.78M
-152.48%-8.32M
-154.84%-3.68M
-176.92%-2.43M
-143.74%-2.21M
-99.68%3K
290.18%15.85M
195.90%6.71M
-Change in prepaid assets
357.68%4.65M
-6,270.75%-6.75M
-47.77%515K
-61.87%480K
-70.32%1.4M
-358.68%-1.8M
91.51%-106K
133.81%986K
138.77%1.26M
1,821.54%4.73M
-Change in payables and accrued expense
11,815.56%5.27M
173.13%988K
-3,067.80%-3.74M
-667.14%-5.58M
-332.99%-4.06M
99.26%-45K
-126.49%-1.35M
-147.39%-118K
-40.85%983K
273.61%1.74M
-Change in other current liabilities
----
21.09%-595K
36.18%-552K
-123.68%-3.22M
----
----
---754K
---865K
364.72%13.61M
----
Cash from discontinued investing activities
Operating cash flow
11.66%-21.12M
14.65%-19.84M
-3.72%-23.25M
15.90%-90.9M
-15.44%-21.33M
24.82%-23.91M
19.50%-23.25M
22.53%-22.41M
-0.24%-108.09M
28.43%-18.48M
Investing cash flow
Cash flow from continuing investing activities
-173.34%-13.35M
-103.47%-2.33M
-202.29%-22.03M
-31.64%96.88M
-542.17%-9.88M
-25.32%18.2M
118.07%67.02M
-74.48%21.53M
80.06%141.72M
-90.65%2.23M
Net PPE purchase and sale
55.35%-221K
55.56%-16K
-5.88%-90K
93.16%-808K
-3.78%-192K
39.93%-495K
99.44%-36K
98.06%-85K
21.87%-11.82M
95.75%-185K
Net investment purchase and sale
-170.22%-13.13M
-103.45%-2.31M
-201.48%-21.94M
-36.38%97.68M
-500.41%-9.69M
-25.80%18.69M
80.42%67.06M
-75.64%21.62M
63.63%153.54M
-91.43%2.42M
Cash from discontinued investing activities
Investing cash flow
-173.34%-13.35M
-103.47%-2.33M
-202.29%-22.03M
-31.64%96.88M
-542.17%-9.88M
-25.32%18.2M
118.07%67.02M
-74.48%21.53M
80.06%141.72M
-90.65%2.23M
Financing cash flow
Cash flow from continuing financing activities
0
-1,550.00%-116K
119.88M
-88.63%69K
-31.40%166K
-105K
-97.79%8K
0
-74.68%607K
-35.47%242K
Net common stock issuance
--0
---380K
--119.74M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--0
7.32%264K
--139K
-19.44%489K
0.00%242K
--1K
-32.04%246K
--0
-36.24%607K
-35.47%242K
Net other financing activities
----
----
----
---420K
---76K
---106K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-1,550.00%-116K
--119.88M
-88.63%69K
-31.40%166K
---105K
-97.79%8K
--0
-74.68%607K
-35.47%242K
Net cash flow
Beginning cash position
13.58%129.3M
116.38%151.58M
8.52%76.98M
93.29%70.93M
24.25%108.02M
20.62%113.84M
-23.98%70.06M
93.29%70.93M
-42.14%36.7M
127.25%86.93M
Current changes in cash
-492.17%-34.47M
-150.90%-22.29M
8,587.83%74.61M
-82.35%6.04M
-94.01%-31.04M
21.76%-5.82M
1,873.94%43.78M
-101.59%-879K
228.10%34.24M
-927.55%-16M
End cash Position
-12.21%94.83M
13.58%129.3M
116.38%151.58M
8.52%76.98M
8.52%76.98M
24.25%108.02M
20.62%113.84M
-23.98%70.06M
93.29%70.93M
93.29%70.93M
Free cash flow
12.55%-21.35M
14.71%-19.86M
-3.72%-23.34M
23.52%-91.71M
-15.33%-21.52M
25.20%-24.41M
34.06%-23.29M
32.45%-22.5M
2.48%-119.91M
38.14%-18.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.66%-21.12M14.65%-19.84M-3.72%-23.25M15.90%-90.9M-15.44%-21.33M24.82%-23.91M19.50%-23.25M22.53%-22.41M-0.24%-108.09M28.43%-18.48M
Net income from continuing operations 17.49%-27.13M41.36%-18.48M14.69%-24.79M24.18%-117.17M27.56%-23.71M18.06%-32.89M28.00%-31.51M23.35%-29.06M-6.18%-154.54M4.86%-32.74M
Operating gains losses -------------59.02%50K-266.67%-35K--------------122K--21K
Depreciation and amortization -41.02%890K-37.68%956K-37.37%997K-13.54%5.64M-41.06%1.01M-15.60%1.51M-4.30%1.53M11.72%1.59M40.54%6.53M29.50%1.71M
Other non cash items -90.00%558K-89.72%533K-66.32%487K396.68%13.03M-22.52%819K1,042.40%5.58M361.21%5.18M39.85%1.45M10,592.00%2.62M887.85%1.06M
Change In working capital 187.00%2.11M-187.65%-6.36M-125,933.33%-3.78M-152.48%-8.32M-154.84%-3.68M-176.92%-2.43M-143.74%-2.21M-99.68%3K290.18%15.85M195.90%6.71M
-Change in prepaid assets 357.68%4.65M-6,270.75%-6.75M-47.77%515K-61.87%480K-70.32%1.4M-358.68%-1.8M91.51%-106K133.81%986K138.77%1.26M1,821.54%4.73M
-Change in payables and accrued expense 11,815.56%5.27M173.13%988K-3,067.80%-3.74M-667.14%-5.58M-332.99%-4.06M99.26%-45K-126.49%-1.35M-147.39%-118K-40.85%983K273.61%1.74M
-Change in other current liabilities ----21.09%-595K36.18%-552K-123.68%-3.22M-----------754K---865K364.72%13.61M----
Cash from discontinued investing activities
Operating cash flow 11.66%-21.12M14.65%-19.84M-3.72%-23.25M15.90%-90.9M-15.44%-21.33M24.82%-23.91M19.50%-23.25M22.53%-22.41M-0.24%-108.09M28.43%-18.48M
Investing cash flow
Cash flow from continuing investing activities -173.34%-13.35M-103.47%-2.33M-202.29%-22.03M-31.64%96.88M-542.17%-9.88M-25.32%18.2M118.07%67.02M-74.48%21.53M80.06%141.72M-90.65%2.23M
Net PPE purchase and sale 55.35%-221K55.56%-16K-5.88%-90K93.16%-808K-3.78%-192K39.93%-495K99.44%-36K98.06%-85K21.87%-11.82M95.75%-185K
Net investment purchase and sale -170.22%-13.13M-103.45%-2.31M-201.48%-21.94M-36.38%97.68M-500.41%-9.69M-25.80%18.69M80.42%67.06M-75.64%21.62M63.63%153.54M-91.43%2.42M
Cash from discontinued investing activities
Investing cash flow -173.34%-13.35M-103.47%-2.33M-202.29%-22.03M-31.64%96.88M-542.17%-9.88M-25.32%18.2M118.07%67.02M-74.48%21.53M80.06%141.72M-90.65%2.23M
Financing cash flow
Cash flow from continuing financing activities 0-1,550.00%-116K119.88M-88.63%69K-31.40%166K-105K-97.79%8K0-74.68%607K-35.47%242K
Net common stock issuance --0---380K--119.74M----------0--0--0--------
Proceeds from stock option exercised by employees --07.32%264K--139K-19.44%489K0.00%242K--1K-32.04%246K--0-36.24%607K-35.47%242K
Net other financing activities ---------------420K---76K---106K----------------
Cash from discontinued financing activities
Financing cash flow --0-1,550.00%-116K--119.88M-88.63%69K-31.40%166K---105K-97.79%8K--0-74.68%607K-35.47%242K
Net cash flow
Beginning cash position 13.58%129.3M116.38%151.58M8.52%76.98M93.29%70.93M24.25%108.02M20.62%113.84M-23.98%70.06M93.29%70.93M-42.14%36.7M127.25%86.93M
Current changes in cash -492.17%-34.47M-150.90%-22.29M8,587.83%74.61M-82.35%6.04M-94.01%-31.04M21.76%-5.82M1,873.94%43.78M-101.59%-879K228.10%34.24M-927.55%-16M
End cash Position -12.21%94.83M13.58%129.3M116.38%151.58M8.52%76.98M8.52%76.98M24.25%108.02M20.62%113.84M-23.98%70.06M93.29%70.93M93.29%70.93M
Free cash flow 12.55%-21.35M14.71%-19.86M-3.72%-23.34M23.52%-91.71M-15.33%-21.52M25.20%-24.41M34.06%-23.29M32.45%-22.5M2.48%-119.91M38.14%-18.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data